Chemours Company (NYSE:CC) Is Looking Good Over The Long Term, Gained Nearly 11.86% Over A Month.

In recent trading session, Chemours Company (NYSE:CC) saw 0.43 million shares changing hands at last check today with its beta currently measuring 1.63. Company’s recent per share price level of $11.88 trading at $0.48 or 4.21% at last check today assigns it a market valuation of $1.78B. That most recent trading price of CC’s stock is at a discount of -114.98% from its 52-week high price of $25.54 and is indicating a premium of 23.15% from its 52-week low price of $9.13. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 3.55 million shares which gives us an average trading volume of 3.64 million if we extend that period to 3-months.

For Chemours Company (CC), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 13 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 10 see the stock as a Buy. 1 analyst(s) advised it as an Underweight.

Chemours Company (NYSE:CC) trade information

Upright in the green today for gaining 4.21%, in the last five days CC remained trading in the green while hitting it’s week-highest on Thursday, 06/26/25 when the stock touched $11.88 price level, subtracting -0.68% to its value on the day. Chemours Company’s shares saw a change of -48.97% in year-to-date performance and have moved 8.00% in past 5-day. Chemours Company (NYSE:CC) showed a performance of 11.86% in past 30-days. Number of shares sold short was 14.33 million shares which calculate 3.53 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 16 to the stock, which implies a rise of 25.75% to its recent value today. Analysts have been projecting 15 as a low price target for the stock while placing it at a high target of 17. It follows that stock’s current price would drop -26.26% in reaching the projected high whereas dropping to the targeted low would mean a loss of -26.26% for stock’s current value.

In 2025, company’s earnings growth rate is likely to be around 32.80% while estimates for its earnings growth in next 5 years are of 33.00%.

CC Dividends

Chemours Company is more likely to be releasing its next quarterly report on 2025-May-06 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt. With an annual yield of 7.05%, the share has a forward dividend of 0.84 which implies that company’s dividend yield remained growing in trailing twelve months while having a 5 year average dividend yield of 4.04%.

Chemours Company (NYSE:CC)’s Major holders

Insiders are in possession of 0.46% of company’s total shares while institution are holding 98.02 percent of that, with stock having share float percentage of 98.47%. Investors also watch the number of corporate investors in a company very closely, which is 98.02% institutions for Chemours Company that are currently holding shares of the company. FMR LLC is the top institutional holder at CC for having 17.52 million shares of worth $395.51 million. And as of 2024-06-30, it was holding 11.7284 of the company’s outstanding shares.

The second largest institutional holder is BLACKROCK INC., which was holding about 16.26 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.8823 of outstanding shares, having a total worth of $366.98 million.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.